ClinConnect ClinConnect Logo
Search / Trial NCT06001944

Investigation of the Efficacy of Blood Flow Restricted Training in Lateral Elbow Tendinopathy

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Aug 18, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Lateral Elbow Tendinopathy Blood Flow Restriction Exercise

ClinConnect Summary

This clinical trial is studying a special type of exercise called blood flow-restricted training to see if it can help people with lateral elbow tendinopathy, commonly known as tennis elbow. The researchers believe that this training can strengthen the muscles without putting too much stress on the injured tendon, which may help with healing. Participants in the study will take part in an 8-week program that includes this training along with physiotherapy sessions, where the blood flow to the arm will be carefully limited to promote recovery.

To be eligible for this trial, participants should be between 18 and 65 years old and have a diagnosis of lateral tendinopathy with a score of 33 or higher on a specific elbow assessment test. However, people with certain conditions, like arthritis, severe shoulder problems, or heart disease, will not be able to join. If you participate, you can expect to follow a structured exercise plan for a couple of months, with support from healthcare professionals to guide you through the process. This study is currently recruiting participants, so if you're looking for new treatment options for elbow pain, this could be a great opportunity to consider.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between 18 and 65 years of age,
  • Lateral tendinopathy diagnosis,
  • Have scored 33 or more out of 100 on the Patient Based Tennis elbow Assessment Test (PRTEE).
  • Exclusion Criteria:
  • Dysfunction in the shoulder, neck and/or chest area,
  • Local or generalized arthritis.
  • The neurological deficit.
  • Radial dysfunction,
  • Limitation of arm functions,
  • A history of shoulder or upper extremity pathology requiring surgery or treatment;
  • Venous thromboembolism
  • Inflammation or other hematological disorders.
  • Coronary artery disease,
  • Peripheral arterial disease or hypertension (systolic/diastolic blood pressure \>140 mm Hg/90 mmHg),
  • To be pregnant,
  • Irritation of median nerves.
  • Irritation of radial nerves.
  • Irritation of the ulnar nerves,
  • The pain score is less than 30 mm.

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Istanbul, Büyükçekmece, Turkey

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Yıldız ANALAY AKBABA, Assoc. prof.

Study Chair

Istanbul University - Cerrahpasa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported